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INTRODUCTION 
Fetal  liver  contains  hematopoietic  and  mesen- 
chymaI  ceils in  addition  to  hepatic  parenchymal 
cells.  Culture  conditions  would  be  expected  to 
favor survival of certain of these cell types  at the 
expense of others (3). In order to study the survival 
of hepadc parenchymal cells in culture, a  marker 
that is specific for differentiated parenchymal cells 
is highly- desirable (5,  12)  Morphologic character- 
ization  is  obviously  inadequate.  Although  histo- 
chemical  localization  of intracellular enzymes  or 
glycogen  may  be helpfuI,  such markers  are  often 
nonspecific and require sacrifice of the cells. Albu- 
min, on the other hand, is a  secreted protein and is 
thought  to  be  synthesized  exclusively  in  hepatic 
parenchymal cells in wvo  (8)  In  the present re- 
port,  a  radioimmunoassay for  human  albumin is 
described and utilized to monitor albumin produc- 
tion by human fetal liver in monolayer culture. 
I~IATERIALS  AND  I~IETHODS 
Tissue Culture 
The cultivation of primary human emb~youic liver 
is reported  elsewhere  (9)  The culture  medium was 
that  of Leibovitz  (L-15,  Microbiological Assomates, 
Inc.,  Bethesda,  Md)  supplemented  with  0042% 
argmine  (HC1),  0.03%  glutaminc  (Microbiological 
Associates, Inc ), 0.1% dextrose, potassium penicillin 
G,  150 pg/ml, streptomycin sulfate, 250 pg/ml,  and 
10% fetal calf serum (FCS)  (Flow" Laboratories, Ine., 
Rockeville, Md.).  Inocula  of 5  X  10  ~ cells in 0.5 ml 
of medium were seeded into 16 X  100 mm constricted 
glass  tubes  (Rochester  Scientific  Co.,  Rochester, 
N. Y.) and incubated in air. The resulting cell growth 
was washed with medium after 2 days and cultivated 
a  further  3  or  more  days  before  the  medium  was 
assayed for human albumin. The number of apparent 
hepatic parenchymal ceils between 3  and  10 days of 
culture  was  appro~mately  constant  by  direct  cell 
counts of stained preparations. 
A  cell hue composed of fibroblasts morphologicaUy 
was derived from a  liver culture that appeared to be 
overrun with fibroblasts on iuitiaI passage.  The line 
was maintained in the standard growth medium and 
continued  to  resemble  fibroblasts,  with  passage  by 
trypsinization every three or four weeks  HeLa cells, 
human muscle-skin fibroblasts, and mouse "L"  cells 
were similarly maintained. Because liver parenchymaI 
cells  in  monolayer  generally  survived  poorly  after 
passage, they were studied in primary culture only. 
Cellulose-Conjugated Antibody and 
RadiolabeIed Albumin 
Bromoacctyl  cellulose  (BAC)  was  prepared  as 
described  by  Robbms  ct  al  (11),  and  sheep  anti- 
human  albumin  (Calbiochem,  Los  Angeles,  Calif.) 
was conjugated to BAC by the method of Mann et al 
(6).  Human  albumin  (grade  III,  Sigma  Chemical 
Co., St. Louis, Mo.) was labeled in the presence of 1.0 
mCi Na-l"-sI  (New  England Nuclear  Corp.,  Boston, 
Mass.)  (7)  The  labeled  albumin  was  freed  of un- 
reacted  1~5I by dialysis against several liters of 0.14 ~f 
saline at 4°C and bad an initial spemfic activity of 0.4 
mCi/mg°  Of the radioactivity in  the final prepara- 
uon, 92 °To was precipitable by antialbumi_n. 
Incubations ~of..BAC-antibody  and  albumin  (6) 
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containing 0. 1% gelatin,  pH  7.40.  For  the study  of 
de novo synthesis of albumin, Eagle's minimal medium 
minus leucine (MEM--L)  was obtained from Grand 
Island BiologicaI  Co.,  Berkeley,  Calif,  and leucine- 
14C  (specific activity,  72  mCi/mmole)  was  obtained 
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~OVRE  1  Titration of  BAC-antibody. Albumiu-125I, 
0.13  #g  (3000-5000 cpm),  was  incubated  in duplicate 
with  serial  dilutions  of  BAC-antihuman  albumin  in 
VBS, as described elsewhere (6). After pelleting of the 
BAC-antibody  with  bound albumin-t25I,  snpernatant 
radioactivity was determined in a well-type scintillation 
counter 
RESWLTS 
The titration of BAC-antibody against a  standard 
quantity of albumin-1:sI  is represented  in Fig.  1. 
An amount of BAC-antibody that bound approxi- 
mately  50%  of  the  added  labeled  albumin  was 
chosen for the standard assay  When this amount 
of  BAC-antibody  and  the  standard  quantity  of 
albumin-12~I were incubated with unlabeled albu- 
min, label was  displaced  to the supernatant.  The 
amount of label displaced was proportional to the 
amount  of unlabeled  albumin present,  when this 
was  in  the  range  0.05-0.50  #g  (Fig.  2),  and  the 
resulting  curve  served  as  a  reference  for  assay of 
unknown  samples.  Because  it  appeared  that  the 
assay was most accurate in a narrower range (0.08- 
0 20 #g),  unknowns were  assayed until a  reading 
on this portion of the reference curve was obtained. 
Volumes  of culture  medium  up  to  0.4  ml  were 
assayed without affecting accuracy  (6). 
Dilutions  of whole  human  serum with compa- 
rable  amounts  of  albumin  gave  a  displacement 
curve that was essentially identical to the reference 
curve (Fig. 2)  Because the culture medium usually 
contained  10%  fetal  calf serum,  bovine  albumin 
was  also  assayed.  It  showed  no  significant cross- 
reactivity,  however,  over the range present  (0. I- 
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FmtmE  ~  The reference curve for radloimmunoassay of  human serum albumin  (lISA).  A  standard 
amount of BAC-antibody (see text) and albumin-l~Z, as in :Fig. 1, were incubated with known amounts 
of mllabeled crystalline human serum albumin (0),  whole human serum  (O), or pure bovine serum al- 
bumin (BSA)  in culture medium  (~).  Mter pelleting of the BAC-complex  (6),  the ratio of counts per 
minute released by unlabeled albumin to the total bindable counts per minute was determined (R/TB). 
The vertical lines represent the standaid deviations fm a  series of determinations carried out with the 
same reagents over a period of several weeks. 
820  Bm~r- No~s TABLE  ][ 
Albumin Production  by  Various  Cell  Cultures 
Culture  Albumin (/Zg,,  tube per day) 
Human  embryonic liver  (5.0, M)*  1.0 
"  (11.5,  M)*  0.6 
"  (4 o, F)*  0.8 
"  (12.7, M)*  1.0 
"  (6.0,  F)*  0.7 
Liber fibrobtast  <0.02  (<0.02):~ 
HeLa  cells  <0  02  (<0.02)$ 
"L"  cells  <0.02 
Human  muscle-skin fibroblast  <0.02 
* Fetal  crown-rump  dimension (era),  sex. 
:~ Cell lysate 
Monolayers  of  human  embryomc  liver,  prepared  as  descmbed  m  Materials  and 
Methods, were grown for 2 days, then washed. The albumin produced during the subse- 
quent S  days was measured  (see legend  to  Fig.  2).  The  line ceils were  grown  to  full 
monolayers  (5-10  days).  Lysates were  prepared  by  repeated  freezing  and  thawing, 
suspended in the original volume of medium,  and assayed for albumin. The standard 
inoculum of trypsinized liver contained 1,07 ~zg albumin. 
TABLE  II 
Leucine-l~C Incorporatzon  into  Albumin  by  Various  Cell  Cultures 
Total secreled albumin  Leucme-14C  m albumin 
(/~g,/tube)  {/x/~moles/tube) 
Culture  Day 5  Day 7  Day  5/Day 7  Day 5  Day 7 Day 5/Day 7 
Liver cells 
I-IS  1.5  2.5  0.60  26  38  0.68 
HS  --  --  21  37  0.56 
FCS  0.5  0.8  8  -- 
FCS  0.3  0.4  7  -- 
Liver fibroblast  --  <0.02  --  0 
Disintegrating liver  --  <0.02  --  0 
cells 
t-Ida cells  <0.02  --  0  -- 
The cultures were  grown  as described  in Materials  and Methods.  Liver  cell  cultures 
contained either  lV~ human  serum (HS)  or 10~0 fetal calf serum (FCS).  At day 2,  the 
cultures were washed and then incubated in MEM  -- L, supplemented with glutamine, 
antibiotics,  as above,  and 1.0  /~Ci/ml leucine-14C. After 3  or 5  days of further incuba- 
tion,  0.2  ml of culture medium  was  taken for  assay of albumin-14C.  The  sample was 
treated  initially  with  a  nonspecific BAC conjugate  (to  guinea pig serum protein)  to 
remove extraneous labeled material, which was pelleted by centrifugation at 1500 g  for 
20 mln (6) andwashed  once.  The  combined  supernatants  were  divided  between  two 
tubes, each containing BAC-antialbumin. Unlabeled albumin was added in excess (100 
~g)  to  one tube of each pair,  the final volumes were adjusted to 0.5 ml with VBS,  and 
the tubes were shaken for 3  hr at room temperature.  After  centrifugation,  the  BAC- 
antibody with bound label was washed with cold  teucine and collected  on  a  Milllpore 
filter  (0.45  /z). The filters were dried  and their radioactivity was determined by liquid 
scintillation counting. Albumin-l~c  was estimated from the  amount  of radioactivity 
displaced  (100-700  cpm/0.1  ml  of original  sample)  from  the BAC-antibody  by  cold 
albumin. Total secreted albumin was measured by the standard radioimmunoassay on 
the same samples of culture medium. 
BlUfF  ]~OTES  821 The  albumin  produced  by cultures  of five dif- 
ferent human fetal livers is shown in Table I. The 
time  course  of such  production  is presented  else- 
where  (2)  Neither  the  culture  medium  nor  cell 
lysates of various other ceils contained  detectable 
albumin. 
The data of Table I suggest that de novo synthesis 
of albumin  is  occurring,  in  that  the  albumin  se- 
creted, over the period tested, exceeds by 50-200 % 
the amount of albumin in the initial ceil inoculum 
(see legend to Table I). Moreover, albumin secre- 
tion during  the first two days in culture has  been 
disregarded.  Further evidence for the de novo  pro- 
duction of albumin was the incorporation by liver 
cell cultures of a labeled amino acid precursor into 
secreted  albumin.  Electrophoresis  of media  from 
liver cell cultures  that  had  been  incubated  with 
leucine-~4C  demonstrated  a  peak  of radioactivity 
migrating with albumin.  The medium from simi- 
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I~mUnE 8  Electrophoresis of enitm'e fluid fi'om liver 
cells and  HeLa cells  incubated  with leucine-14C.  The 
media analyzed were those of the HS liver cell culture 
and tIeLa culture of Table II. The liver cell medium, 
with added cold leucine and carrier albumin (~00 #g), 
was dialyzed against isotonic saline and  then concen- 
trated g0-fold with respect to the volume of the initial 
sample. IteLa cell medium was treated similarly for a 
~o00-fold concentrate.  Each  concentrate  was  electro- 
phoresed  on  cellulose acetate  strips  in  0.05  M Tris- 
barbital buffer, pit 8.8, at 1.5 v/cm for ~ hr. The strips 
were  assayed  for  radioactivity in  a  gas-flow  scanner 
(Tracerlab, Waltham, Mass.) and compared to a refer- 
ence electrophoresls  of  normal  human  sernm  stained 
for protein which demonstrated  the portion of serum 
albumin  (ALB)  and  globulins  (at,  ~e,  ~,  and  3')- 
Bold line, liver cell medium; light line, HeLa medium. 
larly treated HeLa cell cultures gave no such peak 
(Fig  3).  The  albumin-14C  of liver  cell  cultures 
could also be measured  immunologmally through 
its ability to reversibly complex with specific BAC- 
antibody.  No  albumin-Z4C  was  found  in  media 
from  fibroblast  and  HeLa  cultures  treated  in  a 
similar fashion  (Table II). Moreover, in the liver 
cultures,  immunologically  measurable  albumin- 
14C  increased  with  time  to  the  same  extent  that 
total secreted  albumin increased,  as measured  by 
the  standard  radioimmunoassay.  Because  the 
intraceUular  pools  of albumin  and  leucine  were 
unknown,  a quantitative comparison of total albu- 
min secretion and de novo synthesis was not possible. 
The data suggest, however, that secretion and syn- 
thesis closely parallel one another in liver cell cul- 
tures. 
DISCUSSION 
Albumin  secretion  by  cultures  of  rat  hepatoma 
cells has  been demonstrated  previously by immu- 
noprecipitation of newly labeled albumin  (9)  and 
by  complement  fixation  (I0).  Both  techniques, 
however,  are  more  laborious  and  generally  less 
sensitive than  the present  method.  The  coupling 
of antibody to BAC renders the antibody insoluble 
and  thereby  avoids  the  time-consuming  precipi- 
tation steps of other radioimmunoassays,  a  run of 
several dozen tubes can be completed in less than 
4 hr. Its sensitivity, like that of other radioimmauno- 
assays,  depends  primarily  on  the  specific activity 
of the labeled albumin. The sensitivity of the pres- 
ent  assay  proved  to  be  particularly  convenient 
since the albumin of most cultures could be meas- 
ured  without  extensive dilution  of the  unknown 
sample. 
The  incorporation  of  labeled  precursor  into 
albumin by fetaI liver was first demonstrated  sev- 
eral years ago with liver slices and  indicates  that 
human  fetal liver is capable  of albumin synthesis 
(4). The specificity of this function for hepatocytes 
in culture, however, has been questioned with the 
report of albumin synthesis by HeLa cells (1). We 
have been unable to detect albumin in cultures of 
similar ceils (Tables I  and  II); if albumin is pro- 
duced  by HeLa  cells,  the  amount  appears  to  be 
two  or  more  orders  of magnitude  less  than  that 
produced by hepatic parenchymal cells in primary 
culture. The parenchymal cells appear,  moreover, 
to be solely responsible for the albumin measured, 
since the amount secreted correlates well with the 
apparent  extent of parenchymal  cell growth in  a 
mixed culture of human embryonic liver and with 
822  Bm~F NoTes other  indications  of parenchvmal  cell  differenn- 
ation  (2)  Albumin secretion,  therefore,  may  be 
particularly useful for evaluating parenchymal cell 
survival  and  differennatmn  in  tissue  culture  of 
embryonic hver. 
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